Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “pCR Rate”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableStudy completedNCT04475211
What this trial is testing

LILLE COVID RESEARCH NETWORK (Covid-19)

Who this might be right for
Sars-CoV2
University Hospital, Lille 757
Large-scale testing (Phase 3)Looking for participantsNCT06925243
What this trial is testing

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 682
Post-approval studies (Phase 4)Ended earlyNCT04346667
What this trial is testing

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Who this might be right for
SARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more
Government of Punjab, Specialized Healthcare and Medical Education Department 125
Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11
Testing effectiveness (Phase 2)Looking for participantsNCT06596018
What this trial is testing

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Who this might be right for
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 96
Testing effectiveness (Phase 2)Study completedNCT02543255
What this trial is testing

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Who this might be right for
Prostate Cancer
University Health Network, Toronto 76
Testing effectiveness (Phase 2)Looking for participantsNCT04677816
What this trial is testing

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Who this might be right for
Triple Negative Breast CancerVitamin D DeficiencyInvasive Breast Cancer
Wake Forest University Health Sciences 50
Not applicableStudy completedNCT01903889
What this trial is testing

Male Engagement in PMTCT Services

Who this might be right for
HIV
FHI 360 3,806
Testing effectiveness (Phase 2)Looking for participantsNCT06276868
What this trial is testing

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 71
Not applicableStudy completedNCT05673850
What this trial is testing

Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy

Who this might be right for
Breast Neoplasms
Peking University 518
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090031
What this trial is testing

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Who this might be right for
EFSpCR Rate
Qingdao Central Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00545688
What this trial is testing

Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 417
Not applicableUnknownNCT02975115
What this trial is testing

Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization

Who this might be right for
Chronic Myelocytic Leukemia
Seoul St. Mary's Hospital 102
Not applicableStudy completedNCT04108910
What this trial is testing

Morbidity Rate for UTI Through Use of PCR-Based Diagnosis and Management

Who this might be right for
Urinary Tract Infections
Pathnostics 66,381
Not applicableStudy completedNCT01958229
What this trial is testing

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BRoadmap Concept in Chronic Hepatitis B Treatment24-week PCR Negativity of Telbivudine+2 more
National Taiwan University Hospital 23
Not applicableUnknownNCT05085522
What this trial is testing

Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)

Who this might be right for
COVID-19
University Hospital, Strasbourg, France 200
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Very early researchUnknownNCT04130750
What this trial is testing

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

Who this might be right for
Breast CancerNeoadjuvant ChemotherapyDrug Effect
Peking University People's Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06949033
What this trial is testing

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 668
Not applicableLooking for participantsNCT07430579
What this trial is testing

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Who this might be right for
Pathological Complete RemissionObjective Response RateImmune-related Adverse Events+1 more
The Second Hospital of Shandong University 25
Load More Results